Literature DB >> 24332429

G0S2--a new player in leukemia.

Kimberly J Payne1, Sinisa Dovat2.   

Abstract

Entities:  

Keywords:  CML; G0S2; K562; Leukemia; Tumor suppressor

Mesh：

Substances：

Year:  2013        PMID： 24332429      PMCID： PMC4370841          DOI： 10.1016/j.leukres.2013.11.011

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  10 in total

1.  A human putative lymphocyte G0/G1 switch gene containing a CpG-rich island encodes a small basic protein with the potential to be phosphorylated.

Authors:  L Russell; D R Forsdyke
Journal:  DNA Cell Biol       Date:  1991-10       Impact factor: 3.311

2.  Impact of DNA demethylation of the G0S2 gene on the transcription of G0S2 in squamous lung cancer cell lines with or without nuclear receptor agonists.

Authors:  Masashi Kusakabe; Kousuke Watanabe; Noriko Emoto; Naomi Aki; Hidenori Kage; Takahide Nagase; Jun Nakajima; Yutaka Yatomi; Nobuya Ohishi; Daiya Takai
Journal:  Biochem Biophys Res Commun       Date:  2009-10-28       Impact factor: 3.575

3.  The G(0)/G(1) switch gene 2 regulates adipose lipolysis through association with adipose triglyceride lipase.

Authors:  Xingyuan Yang; Xin Lu; Marc Lombès; Geun Bae Rha; Young-In Chi; Theresa M Guerin; Eric J Smart; Jun Liu
Journal:  Cell Metab       Date:  2010-03-03       Impact factor: 27.287

4.  Gene expression profiling of CD34+ cells identifies a molecular signature of chronic myeloid leukemia blast crisis.

Authors:  C Zheng; L Li; M Haak; B Brors; O Frank; M Giehl; A Fabarius; M Schatz; A Weisser; C Lorentz; N Gretz; R Hehlmann; A Hochhaus; W Seifarth
Journal:  Leukemia       Date:  2006-06       Impact factor: 11.528

Review 5.  The G0/G1 switch gene 2 (G0S2): regulating metabolism and beyond.

Authors:  Bradlee L Heckmann; Xiaodong Zhang; Xitao Xie; Jun Liu
Journal:  Biochim Biophys Acta       Date:  2012-09-29

6.  CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling.

Authors:  Katrin Faber; Lars Bullinger; Christine Ragu; Angela Garding; Daniel Mertens; Christina Miller; Daniela Martin; Daniel Walcher; Konstanze Döhner; Hartmut Döhner; Rainer Claus; Christoph Plass; Stephen M Sykes; Steven W Lane; Claudia Scholl; Stefan Fröhling
Journal:  J Clin Invest       Date:  2012-12-03       Impact factor: 14.808

7.  Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing.

Authors:  Yutaka Tokumaru; Keishi Yamashita; Motonobu Osada; Shuji Nomoto; Dong-Il Sun; Yan Xiao; Mohammad Obaidul Hoque; William H Westra; Joseph A Califano; David Sidransky
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

8.  The cytosolic protein G0S2 maintains quiescence in hematopoietic stem cells.

Authors:  Takeshi Yamada; Chun Shik Park; Audrea Burns; Daisuke Nakada; H Daniel Lacorazza
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

9.  Chronic myeloid leukemia stem cell biology.

Authors:  Leslie A Crews; Catriona H M Jamieson
Journal:  Curr Hematol Malig Rep       Date:  2012-06       Impact factor: 3.952

10.  Identification of a protein, G0S2, that lacks Bcl-2 homology domains and interacts with and antagonizes Bcl-2.

Authors:  Christian Welch; Manas K Santra; Wissal El-Assaad; Xiaochun Zhu; Wade E Huber; Richard A Keys; Jose G Teodoro; Michael R Green
Journal:  Cancer Res       Date:  2009-08-25       Impact factor: 12.701
  10 in total
  2 in total

1.  The role of Sprouty1 in the proliferation, differentiation and apoptosis of epidermal keratinocytes.

Authors:  Ping Wang; Yuan Zhou; Jian-Qiang Yang; Lilla Landeck; Min Min; Xi-Bei Chen; Jia-Qi Chen; Wei Li; Sui-Qing Cai; Min Zheng; Xiao-Yong Man
Journal:  Cell Prolif       Date:  2018-07-23       Impact factor: 6.831

2.  The implication of lncRNA expression pattern and potential function of lncRNA RP4-576H24.2 in acute myeloid leukemia.

Authors:  Jifu Zheng; Yuan Song; Zhenjiang Li; Aiping Tang; Yan Fei; Wenfeng He
Journal:  Cancer Med       Date:  2019-09-30       Impact factor: 4.452
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.